These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6435908)

  • 1. Neutrophil chemotactic factor of anaphylaxis (NCF-A) release in aspirin-induced asthma.
    Ortolani C; Capsoni F; Restuccia M; Pastorello E; Riboldi PS; Zocchi M; Zanussi C
    Clin Allergy; 1984 Sep; 14(5):443-52. PubMed ID: 6435908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of neutrophil chemotactic activity in aspirin-induced asthma.
    Hollingsworth HM; Downing ET; Braman SS; Glassroth J; Binder R; Center DM
    Am Rev Respir Dis; 1984 Sep; 130(3):373-9. PubMed ID: 6433757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of aspirin-induced bronchoconstriction by sodium cromoglycate inhalation.
    Martelli NA; Usandivaras G
    Thorax; 1977 Dec; 32(6):684-90. PubMed ID: 414371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neutrophil chemotactic activity (NCA) during aspirin-induced bronchoconstriction.
    Grzelewska-Rzymowska I; Szmidt M; Rozniecki J; Grzegorczyk J
    Allergol Immunopathol (Madr); 1988; 16(2):99-103. PubMed ID: 3293381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced serum neutrophil chemotactic activity was noted in both early and late asthmatic responses during lysine-aspirin bronchoprovocation test in ASA-sensitive asthmatic patients.
    Kim SS; Park HS; Yoon HJ; Lee YM; Lee SK; Nahm DH
    J Korean Med Sci; 2003 Feb; 18(1):42-7. PubMed ID: 12589085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine-induced bronchoconstriction in asthma: role of mast cell-mediator release.
    Cushley MJ; Holgate ST
    J Allergy Clin Immunol; 1985 Feb; 75(2):272-8. PubMed ID: 2981912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma.
    Howarth PH; Durham SR; Lee TH; Kay AB; Church MK; Holgate ST
    Am Rev Respir Dis; 1985 Nov; 132(5):986-92. PubMed ID: 2932989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neutrophil chemotactic activity after administration of aspirin during aspirin tolerance in patients with asthma and aspirin hypersensitivity].
    Szmidt M; Grzelewska-Rzymowska I; Rozniecki J; Grzegorczyk J
    Pneumonol Alergol Pol; 1991; 59(1-2):16-21. PubMed ID: 1843881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma.
    Yoshida S; Amayasu H; Sakamoto H; Onuma K; Shoji T; Nakagawa H; Tajima T
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):171-6. PubMed ID: 9494450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil chemotactic activity in toluene diisocyanate (TDI)-induced asthma.
    Sastre J; Banks DE; Lopez M; Barkman HW; Salvaggio JE
    J Allergy Clin Immunol; 1990 Mar; 85(3):567-72. PubMed ID: 2155957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise-induced release of histamine and neutrophil chemotactic factor in atopic asthmatics.
    Lee TH; Brown MJ; Nagy L; Causon R; Walport MJ; Kay AB
    J Allergy Clin Immunol; 1982 Aug; 70(2):73-81. PubMed ID: 6178768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of salbutamol and inhaled sodium cromoglycate on the airway and neutrophil chemotactic activity in "fog"induced bronchospasm.
    Moscato G; Rampulla C; Dellabianca A; Zanotti E; Candura S
    J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):382-8. PubMed ID: 3139728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of release of neutrophil chemotactic factor (NCF).
    Orr TS; Elliott EV; Altounyan RE; Stern MA
    Clin Allergy; 1980 Jul; 10 Suppl():491-6. PubMed ID: 6821511
    [No Abstract]   [Full Text] [Related]  

  • 14. Bronchial asthma and the neutrophil chemotactic factor.
    Lee TH; Kay AB
    Clin Allergy; 1982 Oct; 12 Suppl():39-45. PubMed ID: 6183024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.
    Israel E; Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Shapiro J; Cohn J; Rubin P; Drazen JM
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1447-51. PubMed ID: 8256883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects.
    Taylor ML; Misso NL; Stewart GA; Thompson PJ
    Clin Exp Allergy; 1996 Feb; 26(2):202-15. PubMed ID: 8835129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of leukocyte cytotoxicity after exercise-induced asthma.
    Moqbel R; Durham SR; Shaw RJ; Walsh GM; MacDonald AJ; Mackay JA; Carroll MP; Kay AB
    Am Rev Respir Dis; 1986 Apr; 133(4):609-13. PubMed ID: 3083743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
    Obase Y; Shimoda T; Tomari SY; Mitsuta K; Kawano T; Matsuse H; Kohno S
    Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of misoprostol on post-aspirin bronchoconstriction in patients with aspirin sensitive asthma].
    Szmidt M; Wasiak W
    Pneumonol Alergol Pol; 1995; 63(9-10):544-52. PubMed ID: 8620177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchial challenge with adenosine causes the release of serum neutrophil chemotactic factor in asthma.
    Driver AG; Kukoly CA; Metzger WJ; Mustafa SJ
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1002-7. PubMed ID: 2024808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.